Publications of Sandra Heskamp

2018

L. Joosten, M. Brom, H. Peeters, S. Heskamp, M. Béhé, O. Boerman and M. Gotthardt. "Enhanced Specific Activity by Multichelation of Exendin-3 Leads To Improved Image Quality and In Vivo Beta Cell Imaging.", 2018. Abstract DOI PMID
S. Lütje, D. Gerrits, J. Molkenboer-Kuenen, K. Herrmann, G. Fracasso, M. Colombatti, O. Boerman and S. Heskamp. "Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors.", 2018. Abstract DOI PMID

S. Heskamp, L. Heijmen, D. Gerrits, J. Molkenboer-Kuenen, E. Ter Voert, K. Heinzmann, D. Honess, D. Smith, J. Griffiths, S. Doblas, R. Sinkus, P. Laverman, W. Oyen, A. Heerschap and O. Boerman. "Response Monitoring with [(18)F]FLT PET and Diffusion-Weighted MRI After Cytotoxic 5-FU Treatment in an Experimental Rat Model for Colorectal Liver Metastases.", 2017. Abstract DOI PMID
S. Heskamp, R. Hernandez, J. Molkenboer-Kuenen, M. Essler, F. Bruchertseifer, A. Morgenstern, E. Steenbergen, W. Cai, C. Seidl, W. McBride, D. Goldenberg and O. Boerman. "α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts.", 2017. Abstract DOI PMID
S. Heskamp, R. Raavé, O. Boerman, M. Rijpkema, V. Goncalves and F. Denat. "(89)Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art (89)Zr Radiochemistry.", 2017. Abstract DOI PMID

K. Chatalic, S. Heskamp, M. Konijnenberg, J. Molkenboer-Kuenen, G. Franssen, M. Clahsen-van Groningen, M. Schottelius, H. Wester, W. van Weerden, O. Boerman and M. de Jong. "Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent.", 2016. Abstract DOI PMID

S. Lütje, S. Heskamp, A. Cornelissen, T. Poeppel, S. van den Broek, S. Rosenbaum-Krumme, A. Bockisch, M. Gotthardt, M. Rijpkema and O. Boerman. "PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status", 2015.
S. Heskamp, O. Boerman, J. Molkenboer-Kuenen, C. Wauters, L. Strobbe, C. Mandigers, P. Bult, W. Oyen, W. van der Graaf and H. van Laarhoven. "Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients.", 2015. Abstract DOI PMID
S. Heskamp, W. Hobo, J. Molkenboer-Kuenen, D. Olive, W. Oyen, H. Dolstra and O. Boerman. "Non-invasive imaging of tumor PD-L1 expression using radiolabeled anti-PD-L1 antibodies", 2015. Abstract/PDF DOI PMID

S. Heskamp, O. Boerman, J. Molkenboer-Kuenen, F. Sweep, A. Geurts-Moespot, M. Engelhardt, W. van der Graaf, W. Oyen and H. van Laarhoven. "Cetuximab reduces the accumulation of radiolabeled bevacizumab in cancer xenografts without altering VEGF expression", 2014. Abstract/PDF DOI PMID
E. Fleuren, Y. Versleijen-Jonkers, S. Heskamp, C. van Herpen, W. Oyen, W. van der Graaf and O. Boerman. "Theranostic applications of antibodies in oncology", 2014. Abstract/PDF DOI PMID
S. Heskamp, O. Boerman, J. Molkenboer-Kuenen, R. Koornstra, S. Linn, W. Oyen, W. van der Graaf and H. van Laarhoven. "Dynamics of IGF-1R Expression During Endocrine Breast Cancer Treatment", 2014. Abstract/PDF DOI PMID
S. Heskamp, H. van Laarhoven, W. van der Graaf, W. Oyen and O. Boerman. "Radionuclide imaging of drug delivery for patient selection in targeted therapy", 2014. Abstract/PDF DOI PMID

S. Heskamp. "Molecular imaging of receptor tyrosine kinases in cancer", 2014. PDF URL

E. Fleuren, Y. Versleijen-Jonkers, S. Heskamp, M. Roeffen, W. Bouwman, J. Molkenboer-Kuenen, H. van Laarhoven, W. Oyen, O. Boerman and W. van der Graaf. "The strength of small: improved targeting of insulin-like growth factor-1 receptor (IGF-1R) with F(ab')Ã¢â€šâ€š-R1507 fragments in Ewing sarcomas", 2013. Abstract/PDF DOI PMID
S. Heskamp, O. Boerman, J. Molkenboer-Kuenen, W. Oyen, W. van der Graaf and H. van Laarhoven. "Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies", 2013. Abstract DOI PMID
S. Heskamp, H. van Laarhoven, W. Oyen, W. van der Graaf and O. Boerman. "Tumor-receptor imaging in breast cancer: a tool for patient selection and response monitoring", 2013. Abstract PMID

S. Heskamp, H. van Laarhoven, J. Molkenboer-Kuenen, W. Bouwman, W. van der Graaf, W. Oyen and O. Boerman. "Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507", 2012. Abstract/PDF DOI PMID
S. Heskamp, P. Laverman, D. Rosik, F. Boschetti, W. van der Graaf, W. Oyen, H. van Laarhoven, V. Tolmachev and O. Boerman. "Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer", 2012. Abstract/PDF DOI PMID

K. Aben, S. Heskamp, M. Janssen-Heijnen, E. Koldewijn, C. van Herpen, L. Kiemeney, E. Oosterwijk and D. van Spronsen. "Better survival in patients with metastasised kidney cancer after nephrectomy: a population-based study in the Netherlands", 2011.
E. Fleuren, Y. Versleijen-Jonkers, A. van de Luijtgaarden, J. Molkenboer-Kuenen, S. Heskamp, M. Roeffen, H. van Laarhoven, P. Houghton, W. Oyen, O. Boerman and W. van der Graaf. "Predicting IGF-1R therapy response in bone sarcomas: immuno-SPECT imaging with radiolabeled R1507", 2011. Abstract DOI PMID

S. Heskamp, H. van Laarhoven, J. Molkenboer-Kuenen, G. Franssen, Y. Versleijen-Jonkers, W. Oyen, W. van der Graaf and O. Boerman. "ImmunoSPECT and immunoPET of IGF-1R expression with the radiolabeled antibody R1507 in a triple-negative breast cancer model", 2010. Abstract/PDF DOI PMID

G. de Jong, O. Boerman, S. Heskamp, F. Aarts, R. Bleichrodt and T. Hendriks. "Radioimmunotherapy prevents local recurrence of colonic cancer in an experimental model", 2009. Abstract DOI PMID
G. de Jong, T. Hendriks, A. Eek, W. Oyen, S. Heskamp, R. Bleichrodt and O. Boerman. "Radioimmunotherapy improves survival of rats with microscopic liver metastases of colorectal origin", 2009. Abstract/PDF DOI PMID